Abstract
Visceral adiposity is an important correlate of cardiometabolic risk, yet its association after the diagnosis of type 2 diabetes remains unclear [Smith JD et al. J Clin Endocrinol Metab 2012]. This article discusses the association between visceral adiposity, fatty liver, and cardiometabolic risk, and presents results from the International Study of Prediction of Intra-Abdominal Adiposity and Its Relationships with Cardiometabolic Risk/Intra-Abdominal Adiposity [INSPIRE ME IAA; Smith JD et al. J Clin Endocrinol Metab 2012].
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
